Form 4: Agenus Inc. Director Jennifer Buell Receives Stock in Lieu of Cash as Part of Compensation Plan

Director Jennifer Buell received 1,159 shares of Agenus Inc. common stock as part of her compensation, in lieu of cash, as approved by the Agenus Inc. Compensation Committee.

Summary

• On April 4, 2025, Jennifer Buell, a director of Agenus Inc., acquired 1,159 shares of common stock.
• These shares were received as part of her salary, in lieu of cash, with the approval of the Agenus Inc. Compensation Committee.
• The price per share was $1.56, which was the closing price of Agenus Inc. common stock on April 4, 2025.
• The shares were issued under the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.
• She also disposed of 18,288 shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The transaction is part of a pre-existing compensation plan, indicating stability and alignment of interests. The use of stock in lieu of cash could be seen as a positive for the company's cash flow.

Positives

• The compensation plan demonstrates a commitment to aligning director interests with shareholder value by providing equity.
• The shares are fully vested immediately, incentivizing the director.
• The use of stock in lieu of cash may help the company conserve cash resources.

Management Comments

• The shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

Industry Context

Stock-based compensation is a common practice in the biotechnology industry to attract and retain talent while conserving cash, especially for companies in the development stage like Agenus.

Comparison to Industry Standards

• Many biotech companies use equity compensation plans to align the interests of executives and directors with those of shareholders.
• Companies like Amgen, Gilead, and Biogen also utilize stock options and restricted stock units as part of their compensation packages.
• The specific amount and vesting schedules can vary widely based on company size, performance, and individual roles.

Stakeholder Impact

• Shareholders may view the stock compensation positively as it aligns the director's interests with the company's performance.
• Employees may see this as a sign of the company's commitment to its leadership.

Key Dates

Keywords

Agenus Inc., Jennifer Buell, Director, Stock Compensation, Equity Incentive Plan, Form 4, Beneficial Ownership